FRANKLIN RESOURCES INC - 30 Sep 2025 SCHEDULE 13G/A Report for Acumen Pharmaceuticals, Inc. Common stock, par value $0.0001 per share (ABOS)

Filing Manager
FRANKLIN RESOURCES INC
Reporting Manager
Franklin Resources, Inc.
Security
Acumen Pharmaceuticals, Inc. Common stock, par value $0.0001 per share
Symbol
ABOS
Shares outstanding
60,660,421 shares
Disclosed Ownership
2,305,096 shares
Ownership
3.8%
Form type
SCHEDULE 13G/A
Filing time
04 Nov 2025, 11:25:30 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"FRANKLIN RESOURCES INC disclosed 3.8% ownership in Acumen Pharmaceuticals, Inc. Common stock, par value $0.0001 per share (ABOS) on 30 Sep 2025."

Quick Takeaways

  • FRANKLIN RESOURCES INC filed SCHEDULE 13G/A for Acumen Pharmaceuticals, Inc. Common stock, par value $0.0001 per share (ABOS).
  • Disclosed ownership: 3.8%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 04 Nov 2025, 11:25.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Franklin Resources, Inc. 3.8% 2,305,096 2,305,096 0 /s/Thomas C. Mandia Thomas C. Mandia, Assistant Secretary of Franklin Resources, Inc.
Charles B. Johnson 0% 0 0 0 /s/Thomas C. Mandia Attorney in Fact for Charles B. Johnson pursuant to Power of Attorney attached to this Schedule 13G
Rupert H. Johnson, Jr. 0% 0 0 0 /s/Thomas C. Mandia Attorney in Fact for Rupert H. Johnson, Jr. pursuant to Power of Attorney attached to this Schedule 13G

Sponsored